Cresco Labs Inc. (OTC: CRLBF)

Cresco Labs Inc. is a vertically-integrated multi-state cannabis operator, licensed to cultivate, manufacture, and sell retail and medical cannabis products. The company operates in the cannabis industry, with a strategic geographic footprint and a portfolio of industry-leading brands. Cresco Labs generates revenue through its vertically-integrated operations, which include cultivation, manufacturing, and retail sales. The company's primary products include a range of cannabis brands such as Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal, Remedi, Mindy's, and Loudr. These products cater to both medical and adult-use markets, with a focus on quality, consistency, and innovation. Cresco Labs serves a diverse customer base, including medical cannabis patients and adult-use consumers, through its Sunnyside dispensaries and wholesale distribution to third-party retail stores.

• Consolidated Wholesale: This segment focuses on the wholesale distribution of cannabis products. Cresco Labs' portfolio consists of over 500 unique products and over 6,600 unique stock-keeping-units (SKUs), which are sold in nearly 1,400 dispensaries across the country. The company's CPG-focused wholesale strategy enables it to maximize points of distribution and drive revenue growth independent of the expansion of its retail presence.

• Consolidated Retail: This segment includes the operation of Sunnyside dispensaries, which serve as a critical platform for innovation and powerful consumer insights. As of March 5, 2026, Cresco Labs operates 73 dispensaries, providing a direct sales channel for its products and a means to educate and build trust within the surrounding communities.

Cresco Labs holds a significant position within the cannabis industry, competing with other multi-state operators such as Curaleaf, Green Thumb Industries, and Trulieve. The company's competitive advantages include its strategic geographic footprint, industry-leading brands, highly productive retail operations, and one of the leading distribution platforms in North America. Cresco Labs' focus on CPG brand building and its ability to place its branded products on the shelves of the most important dispensaries in targeted states drive best-in-class sell-through and menu assortment.

The company's customer base includes medical cannabis patients and adult-use consumers, who are served through its Sunnyside dispensaries and wholesale distribution to third-party retail stores. Cresco Labs' products cater to a wide range of consumer needs and preferences, with a focus on quality, consistency, and innovation. The company's commitment to trust, education, and convenience for both existing and new cannabis consumers reinforces its competitive advantage in the market.